Sheetal Kircher

2.8k total citations · 1 hit paper
108 papers, 1.8k citations indexed

About

Sheetal Kircher is a scholar working on Oncology, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sheetal Kircher has authored 108 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Oncology, 39 papers in Economics and Econometrics and 29 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sheetal Kircher's work include Economic and Financial Impacts of Cancer (32 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers) and Palliative Care and End-of-Life Issues (16 papers). Sheetal Kircher is often cited by papers focused on Economic and Financial Impacts of Cancer (32 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers) and Palliative Care and End-of-Life Issues (16 papers). Sheetal Kircher collaborates with scholars based in United States, Philippines and Canada. Sheetal Kircher's co-authors include Al B. Benson, Robert W. Lentz, Mary F. Mulcahy, Halla Nimeiri, Aparna Kalyan, Suneel D. Kamath, Hiral Shah, Angela J. Fought, Nisha Mohindra and Sofia F. Garcia and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Sheetal Kircher

107 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies

2019 230 citations Al B. Benson, Sheetal Kircher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sheetal Kircher United States	22	972	434	251	222	218	108	1.8k
Aakash Desai United States	23	797 0.8×	253 0.6×	111 0.4×	249 1.1×	170 0.8×	139	1.9k
Robin Zoň United States	25	931 1.0×	283 0.7×	333 1.3×	161 0.7×	136 0.6×	71	2.1k
Sidney Scudder United States	20	603 0.6×	246 0.6×	397 1.6×	156 0.7×	206 0.9×	49	1.9k
Reda Wilson United States	20	985 1.0×	140 0.3×	265 1.1×	431 1.9×	153 0.7×	42	2.3k
Julien Péron France	28	1.0k 1.1×	255 0.6×	151 0.6×	152 0.7×	100 0.5×	121	2.1k
Alice Nennecke Germany	14	1.2k 1.2×	217 0.5×	184 0.7×	310 1.4×	233 1.1×	36	2.0k
Nancy Roach United States	19	788 0.8×	189 0.4×	275 1.1×	423 1.9×	366 1.7×	35	1.7k
Joleen M. Hubbard United States	24	1.6k 1.7×	183 0.4×	259 1.0×	138 0.6×	601 2.8×	152	2.5k
Christel Rushing United States	20	662 0.7×	531 1.2×	131 0.5×	239 1.1×	58 0.3×	68	1.7k
Janette K. Merrill United States	14	839 0.9×	124 0.3×	359 1.4×	303 1.4×	178 0.8×	33	1.7k

Countries citing papers authored by Sheetal Kircher

Since Specialization

Citations

This map shows the geographic impact of Sheetal Kircher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheetal Kircher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheetal Kircher more than expected).

Fields of papers citing papers by Sheetal Kircher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheetal Kircher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheetal Kircher. The network helps show where Sheetal Kircher may publish in the future.

Co-authorship network of co-authors of Sheetal Kircher

This figure shows the co-authorship network connecting the top 25 collaborators of Sheetal Kircher. A scholar is included among the top collaborators of Sheetal Kircher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheetal Kircher. Sheetal Kircher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kircher, Sheetal, et al.. (2025). Disparities Along the Cancer Care Continuum. 5(1). 267–281.

Kircher, Sheetal, et al.. (2024). Oncologic drug repository programs in the United States: a review and comparison. Health Affairs Scholar. 2(3). qxae031–qxae031. 1 indexed citations

Mohindra, Nisha, Sofia F. Garcia, Sheetal Kircher, et al.. (2024). Development of an electronic health record-integrated patient-reported outcome-based shared decision-making dashboard in oncology. JAMIA Open. 7(3). ooae056–ooae056. 5 indexed citations

Erickson, Kristin A., James E. Norton, Jennifer Law, et al.. (2024). Prevention of allergic reactions during oxaliplatin desensitization through inhibition of Bruton tyrosine kinase. Journal of Allergy and Clinical Immunology. 154(1). 222–228.e4. 3 indexed citations

Yanez, Betina R., Laura M. Perry, John Devin Peipert, et al.. (2024). Exploring the Relationship Among Financial Hardship, Anxiety, and Depression in Patients With Cancer: A Longitudinal Study. JCO Oncology Practice. 20(12). 1776–1783. 5 indexed citations

O’Connor, Mary, John Devin Peipert, Sofia F. Garcia, et al.. (2024). Implementation of a Co-Design Strategy to Develop a Dashboard to Support Shared Decision Making in Advanced Cancer and Chronic Kidney Disease. Journal of Clinical Medicine. 13(14). 4178–4178. 1 indexed citations

Spring, Bonnie, Sofia F. Garcia, Maia Jacobs, et al.. (2024). Scalable Telehealth Cancer Care: integrated healthy lifestyle program to live well after cancer treatment. JNCI Monographs. 2024(64). 83–91. 2 indexed citations

Gordon, Andrew C., Sheetal Kircher, Al B. Benson, et al.. (2024). Yttrium-90 Radiation Segmentectomy for Treatment of Neuroendocrine Liver Metastases. Journal of Vascular and Interventional Radiology. 36(2). 293–300. 1 indexed citations

Kircher, Sheetal, et al.. (2024). Neoadjuvant Chemotherapy in Colon Cancer: More Than Just an Optical Illusion. Journal of Clinical Oncology. 42(25). 2949–2954. 1 indexed citations

10.

Mahalingam, Devalingam, Siqi Chen, Ping Xie, et al.. (2023). Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC). British Journal of Cancer. 129(5). 782–790. 12 indexed citations

11.

Mulcahy, Mary F., Sheetal Kircher, Christopher George, et al.. (2023). Enhancement and Implementation of a Health Information Technology Module to Improve the Discrete Capture of Cancer Staging in a Diverse Regional Health System. JCO Oncology Practice. 19(10). e957–e966. 1 indexed citations

12.

Yanez, Betina R., Diana Buitrago, Justin D. Smith, et al.. (2023). Effectiveness and implementation of an electronic health record-integrated digital health intervention for managing depressive symptoms in ambulatory oncology: The My Well-Being Guide study rationale and protocol. Contemporary Clinical Trials. 127. 107121–107121. 2 indexed citations

13.

Gordon, Andrew C., Ahmed Gabr, Aparna Kalyan, et al.. (2022). Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient Cohort. CardioVascular and Interventional Radiology. 45(8). 1117–1128. 13 indexed citations

14.

Kaiser, Karen, et al.. (2020). Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale. World Journal of Gastrointestinal Oncology. 12(2). 205–218. 12 indexed citations

15.

Webster, Kimberly, Mary O’Connor, Aaron R. Hansen, et al.. (2020). Development of a Functional Assessment of Chronic Illness Therapy item library and primary symptom list for the assessment of patient-reported adverse events associated with immune checkpoint modulators. Journal of Cancer Metastasis and Treatment. 2020. 6 indexed citations

16.

Garcia, Sofia F., Katy Wortman, David Cella, et al.. (2019). Implementing electronic health record–integrated screening of patient‐reported symptoms and supportive care needs in a comprehensive cancer center. Cancer. 125(22). 4059–4068. 50 indexed citations

17.

Kircher, Sheetal, et al.. (2017). Screening for Recurrence and Secondary Cancers. Medical Clinics of North America. 101(6). 1167–1180. 7 indexed citations

18.

Hickey, Ryan, Laura Kulik, Halla Nimeiri, et al.. (2017). Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures. Journal of Vascular and Interventional Radiology. 28(11). 1487–1494. 27 indexed citations

19.

Kircher, Sheetal, Halla Nimeiri, & Al B. Benson. (2016). Targeting Angiogenesis in Colorectal Cancer. The Cancer Journal. 22(3). 182–189. 27 indexed citations

20.

Kircher, Sheetal, Sandeep Gurbuxani, & Sonali M. Smith. (2007). CHOP Plus Alemtuzumab can Induce Metabolic Response by FDG-PET but has Minimal Long-term benefits: A Case Report and Literature Review. Journal of Gastrointestinal Cancer. 38(1). 59–62. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact